Antiepileptic drugs and relapse after epilepsy surgery

Epileptic Disorders

Volumn 10, Issue 3, 2008, Pages 193-198

  Asadi Pooya, Ali A ^a,b   Nei, Maromi ^a,b   Sharan, Ashwini D ^a,b   Mintzer, Scott ^a,b   Zangaladze, Andro ^a,b   Evans, James G ^a,b   Skidmore, Christopher ^a,b   Sperling, Michael R ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Epilepsy surgery; Epileptogenesis; Mechanism of action; Neuroprotection; Seizure relapse

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EPILEPSY; EPILEPTOGENESIS; FEMALE; HIPPOCAMPAL SCLEROSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NEUROPROTECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TEMPORAL LOBECTOMY;

ADULT; ANTERIOR TEMPORAL LOBECTOMY; ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SCLEROSIS; TEMPORAL LOBE;

EID: 53349100315     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: 10.1684/epd.2008.0198     Document Type: Article

References (26)

1. Bernasconi N, Natsume J, Bernasconi A. Progression in temporal lobe epilepsy, differential atrophy in mesial temporal structures. Neurology 2005; 65: 223-8.
2. Chelune GJ, Naugle RI, Hermann BP, et al. Does presurgical IQ predict seizure outcome after temporal lobectomy? Evidence from the Bozeman Epilepsy Consortium. Epilepsia 1998; 39: 314-8.
3. DeGraba TJ, Pettigrew LC. Why do neuroprotective drugs work in animals but not humans? Neurol Clin 2000; 18: 475-93.
4. Faden AI, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol 2007; 64: 794-800.
5. Fery LC. Epidemiology of post-traumatic epilepsy: a critical review. Epilepsia 2003; 44 (Suppl. 10): 11-7.
6. Gamble C, Williamson PR, Chadwick DW, et al. A Meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology 2006; 66: 1310-7.
7. Goldstein LB. Rehabilitation and recovery after stoke. Curr Treat Options Neurol 2000; 2: 319-28.
8. Herman ST. Clinical trials for prevention of epileptogenesis. Epil Research 2006; 68: 35-8.
9. Hernandez TD. Preventing post-traumatic epilepsy after brain injury: weighing the costs and benefits of anticonvulsant prophylaxis. Trends Pharmacol Sci 1997; 8: 59-62.
10. Jadhav V, Solaroglu I, Obenaus A, et al. Neuroprotection against surgically induced brain injury. Surg Neurol 2007; 67:15-20.
11. Jeong S-W, Lee SK, Hong K-S, et al. Prognostic factors for the surgery for mesial temporal lobe epilepsy: longitudinal analysis. Epilepsia 2005; 46: 1273-9.
12. Klitgaard H, Pitkanen A. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam. Epileptic Disord 2003; 5(Suppl. 1): S9-S16.
13. Krupp E, Heynen T, Li XL, et al. Tolerance to the anticonvulsant effects of lamotrigine on amygdala kindled seizures: cross-tolerance to carbamazepine but not valproate or diazepam. Exp Neurol 2000; 162: 278-89.
14. Marson AG, Williamson PR, Clough H, et al. Epilepsy Monotherapy Trial Group Carbamazepine versus Valproate Monotherapy for epilepsy: a meta-analysis. Epilepsia 2002; 43: 505-13.
15. Motamedi M, Nguyen DK, Zaatreh M, et al. Levetiracetam efficacy in refractory partial-onset seizures, especially after failed epilepsy surgery. Epilepsia 2003; 44: 211-4.
16. Owen AJ, Ijaz S, Miyashita H, et al. Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study. Brain Res 1997; 770: 115-22.
17. Pitkanen A. Drug-mediated neuroprotection and antiepileptogenesis: animal data. Neurology 2002; 59: S27-S33.
18. Ryvlin P, Montavont A, Nighoghossian N. Optimizing therapy of seizures in stroke patients. Neurology 2006; 67: S3-S9.
19. Schubert S, Brandl U, Brodhun M, et al. Neuroprotective effects of topiramate after hypoxia-ischemia in newborn piglets. Brain Res 2005; 1058: 129-36.
20. Stepien K, Tomaszewski M, Czuczwar SJ. Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs - an update. Pharmacol Rep 2005; 57: 719-33.
21. Temkin NR. Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 2001; 42: 515-24.
22. Wang H, Gao J, Lassiter TF, et al. Levetiracetam is neuroprotective in murine models of closed head injury and subarachnoid hemorrhage. Neurocrit Care 2006; 5: 71-8.
23. Weiss SR, Post RM. Carbamazepine and carbamazepine-10, 1-epoxide inhibit amygdala-kindled seizures in the rat but do not block their development. Clin Neuropharmacol 1987; 10: 272-9.
24. Willmore LJ. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav 2005; 7 (Suppl. 3): S25-S28.
25. Yang Y, Li Q, Wang CX, et al. Dose-dependent neuroprotection with tiagabine in a focal cerebral ischemia model in rat. Neuroreport 2000; 11: 2307-11.
26. Zaremba PD, Bialek M, Blaszczyk B, et al. Non-epilepsy uses of antiepileptic drugs. Pharmacol Rep 2006; 58: 1-12.